Immune globulin is a concentrated solution of antibodies collected from human blood plasma, and it’s used to treat two broad categories of conditions: immune deficiencies where the body can’t make enough of its own antibodies, and autoimmune or inflammatory diseases where the immune system attacks healthy tissue. It’s one of the most versatile therapies in medicine, with FDA-approved uses spanning infections, blood disorders, nerve diseases, and childhood inflammatory conditions.
Replacing Missing Antibodies
The original and most straightforward use of immune globulin is as replacement therapy for people with primary immunodeficiency disorders. These are inherited conditions where the body produces little to no antibodies on its own, leaving a person vulnerable to repeated, serious infections. The therapy dates back to the 1950s, when a physician named Bruton first administered immune globulin to a child who couldn’t produce antibodies at all.
Today, immune globulin replacement is standard care for a range of immunodeficiency diagnoses. Some patients have extremely low total antibody levels in their blood, while others have normal overall levels but can’t produce antibodies against specific threats. In either case, the infused antibodies do what the patient’s own immune system cannot: neutralize viruses, inactivate bacterial toxins, and flag pathogens for destruction. For most of these patients, treatment is lifelong, with infusions given on a regular schedule to maintain protective antibody levels.
Treating Autoimmune and Inflammatory Conditions
Beyond filling in for a weak immune system, immune globulin can also calm an overactive one. At higher doses, it shifts from a replacement therapy to an immunomodulatory one, dampening the harmful inflammation that drives autoimmune diseases. The FDA has approved it for several specific conditions in this category.
Immune thrombocytopenic purpura (ITP) is an autoimmune blood disorder where the body destroys its own platelets, the cells responsible for clotting. Without enough platelets, even minor injuries can cause dangerous bleeding. Immune globulin can raise platelet counts within about four days of administration, and it’s now considered a first-line treatment alongside steroids.
Kawasaki disease is an inflammatory condition that primarily affects children under five, causing fever, rash, and swelling of blood vessels, particularly the coronary arteries surrounding the heart. Immune globulin given early in the illness significantly reduces the risk of lasting heart damage.
Chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy are neurological conditions where the immune system attacks the protective coating around nerves, causing progressive weakness and numbness. Immune globulin is an approved treatment for both and often produces noticeable improvement in strength and function.
It’s also approved for use in patients who’ve received bone marrow transplants, those with a type of blood cancer called B-cell chronic lymphocytic leukemia, and people with HIV infection who have recurrent bacterial infections.
How It Works in the Body
When used as replacement therapy, the mechanism is simple: you’re borrowing antibodies from thousands of healthy donors. Those antibodies circulate in your bloodstream and do the same jobs your own would, neutralizing pathogens and tagging them for removal.
The immunomodulatory effects are more complex. At higher doses, the infused antibodies interact with receptors on immune cells like macrophages, B cells, and natural killer cells. One key mechanism involves blocking the receptors that macrophages use to destroy cells tagged by harmful autoantibodies. This is why it works so quickly in ITP: the macrophages that would normally gobble up antibody-coated platelets are essentially distracted.
Immune globulin also contains a vast diversity of antibodies from its donor pool, including some that can bind to and neutralize the specific autoantibodies causing disease. Think of it as antibodies against antibodies. On top of that, it reduces complement activation (a chain reaction in the blood that amplifies inflammation) and shifts the balance of inflammatory signaling molecules toward a calmer state.
Off-Label Uses
Because of its broad anti-inflammatory properties, immune globulin is frequently prescribed off-label for conditions beyond its official approvals. In dermatology, it’s used for bullous pemphigoid, a blistering skin disease. One randomized trial found that patients who received immune globulin after failing steroid therapy saw an 85% reduction in the time needed before treatment could be scaled back, compared to 53% with placebo.
In rheumatology, it’s used for systemic lupus erythematosus, where a pooled analysis of six studies found it significantly reduced disease activity scores and allowed patients to lower their daily steroid dose by an average of about 18 milligrams. It’s also used in dermatomyositis and polymyositis (inflammatory muscle diseases) and in antiphospholipid syndrome, a clotting disorder particularly dangerous during pregnancy. In one study, pregnant patients with antiphospholipid syndrome who received immune globulin as part of combination therapy showed significant regression of a type of heart block in their babies.
How It’s Given
Immune globulin comes in two main forms: intravenous (IV) and subcutaneous (under the skin). The choice between them often comes down to lifestyle preference and how your body tolerates each option.
Intravenous infusions are typically given every three to eight weeks in a hospital or infusion center. Each session can take several hours. The upside is fewer appointments per month. Subcutaneous infusions are given more frequently, often weekly or even twice weekly, but they’re shorter and can be done at home with a small pump or autoinjector. Many patients prefer the independence of home treatment, while others prefer the less frequent schedule of IV infusions.
Dosing depends entirely on the reason for treatment. For immune deficiency replacement, a typical maintenance dose is 400 to 800 milligrams per kilogram of body weight each month. For autoimmune and inflammatory conditions, the dose is substantially higher, typically around 2 grams per kilogram, spread over two to five days. Some patients with autoimmune conditions receive treatment for a defined period. One study of patients with autoimmune nerve disease found the average treatment duration was about two years, though people with primary immunodeficiency generally remain on therapy indefinitely.
Side Effects
Most side effects are mild and happen during or shortly after the infusion. Flu-like symptoms are by far the most common, affecting more than 80% of reported reactions. These include headache, flushing, nausea, fatigue, fever, chills, and general achiness. They’re usually temporary and tend to improve with slower infusion rates or premedication with acetaminophen or antihistamines.
Serious reactions are rare but possible. One important risk factor is IgA deficiency, a condition where the body makes very little of one specific antibody type called IgA. People with undetectable IgA levels can develop antibodies against IgA itself. If they then receive a standard immune globulin product (which contains some IgA), those anti-IgA antibodies can trigger a severe allergic reaction, including dangerously low blood pressure and difficulty breathing. For these patients, subcutaneous immune globulin is a safer alternative, as it’s associated with a lower risk of anaphylaxis. Patients are typically screened for IgA deficiency before starting therapy.
Where the Antibodies Come From
Immune globulin is manufactured from pooled human plasma collected from thousands of blood and plasma donors. The manufacturing process involves multiple purification and viral inactivation steps to isolate the antibody fraction while removing or destroying potential contaminants. Because the plasma comes from such a large and diverse donor pool, the final product contains antibodies against a wide range of pathogens and immune targets. This diversity is actually essential to its effectiveness, both for fighting infections and for the immunomodulatory properties that make it useful in autoimmune disease.